AZD3293 Thorough QT Study in Healthy Male Volunteers
Completed · Phase 1 · Has a placebo group
Conditions studied: Alzheimer's Disease
In brief
A thorough QT study of AZD3293
Key facts
- Study ID
- NCT02040987
- Run by
- AstraZeneca
- People needed
- 52
- Starts
- 2014-01-01
- Expected to finish
- 2014-05-01
- Last updated by the study team
- 2014-07-03
Who can join
Age: 18 and older, up to 55. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- Provision of signed, written and dated informed consent prior to any study-specific procedures
- Healthy male subjects must be able to understand and be willing to comply with study procedures, restrictions and requirements
- Healthy male subjects aged 18 to 55 years
- Body weight ≥ 50 to ≤ 100 kg and body mass index (BMI) ≥19 to ≤30
- Clinically normal findings on physical examination in relation to age, as judged by the investigator.
You may not qualify if…
- History of any clinically significant disease or disorder which may either put the subject at risk because of participation in the study, or influence the results or the subject's ability to participate in the study
- History or presence of gastrointestinal, hepatic or renal disease or any other condition known to interfere with absorption, distribution, metabolism or excretion of drugs
- History of previous or ongoing psychiatric disease/condition including psychosis, affective disorder, anxiety disorder, borderline state and personality disorder
- History of neurologic disease, including seizures (with the exception of febrile infantile seizures), recent memory impairment or clinically significant head injury
- History of psychotic disorder among first degree relatives
Where it is running
- Research Site — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.